Article Details

Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist ...

Retrieved on: 2024-07-12 19:01:35

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist .... View article details on hiswai:

Excerpt

NEW YORK, NY, USA I July 11, 2024 I Pfizer Inc. (NYSE: PFE) today announced that based on results from the ongoing pharmacokinetic study ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up